IRIS
PRETE, MARCELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.260
AS - Asia 3.274
EU - Europa 2.937
SA - Sud America 831
AF - Africa 158
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 13.472
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.150
SG - Singapore 1.335
IT - Italia 994
CN - Cina 701
BR - Brasile 643
SE - Svezia 410
HK - Hong Kong 409
RU - Federazione Russa 326
VN - Vietnam 265
DE - Germania 261
FR - Francia 242
FI - Finlandia 176
GB - Regno Unito 155
UA - Ucraina 146
IN - India 112
BD - Bangladesh 78
AR - Argentina 72
ID - Indonesia 48
IQ - Iraq 44
MX - Messico 43
TR - Turchia 43
JP - Giappone 42
CA - Canada 41
CI - Costa d'Avorio 40
NL - Olanda 36
ZA - Sudafrica 36
ES - Italia 31
PL - Polonia 31
EC - Ecuador 30
PH - Filippine 29
PK - Pakistan 29
VE - Venezuela 24
BE - Belgio 22
AT - Austria 21
SA - Arabia Saudita 21
UZ - Uzbekistan 20
CO - Colombia 19
IE - Irlanda 19
MA - Marocco 18
CL - Cile 17
CZ - Repubblica Ceca 15
TN - Tunisia 14
CH - Svizzera 12
MY - Malesia 12
TW - Taiwan 12
JO - Giordania 11
PY - Paraguay 10
KE - Kenya 9
LT - Lituania 9
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
DZ - Algeria 7
PS - Palestinian Territory 7
SY - Repubblica araba siriana 7
EG - Egitto 6
PE - Perù 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
EU - Europa 5
KR - Corea 5
SN - Senegal 5
AU - Australia 4
HR - Croazia 4
IL - Israele 4
UY - Uruguay 4
AL - Albania 3
AO - Angola 3
BB - Barbados 3
BO - Bolivia 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MD - Moldavia 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BG - Bulgaria 2
CR - Costa Rica 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
LB - Libano 2
MT - Malta 2
NG - Nigeria 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
SR - Suriname 2
AM - Armenia 1
BH - Bahrain 1
BJ - Benin 1
BT - Bhutan 1
BW - Botswana 1
BZ - Belize 1
Totale 13.448
Salva come PNG Salva come JPEG
Città #
Singapore 734
Ashburn 665
Chandler 595
Fairfield 443
Hong Kong 407
San Jose 373
Woodbridge 373
Jacksonville 342
Nyköping 331
Houston 292
Beijing 251
Seattle 224
Bari 217
Ann Arbor 215
Cambridge 203
Wilmington 192
New York 134
Lauterbourg 109
Roxbury 104
Lawrence 103
Los Angeles 91
Nanjing 91
Helsinki 86
Ho Chi Minh City 85
Milan 81
Dallas 78
Des Moines 71
Munich 64
São Paulo 60
Hanoi 59
Boardman 56
Princeton 49
Brooklyn 48
Santa Clara 46
Inglewood 44
Council Bluffs 42
Abidjan 40
Buffalo 40
Moscow 38
Falkenstein 33
Marseille 32
Orem 32
Chicago 31
Rome 31
Tokyo 29
Jakarta 28
London 28
Pune 27
Shenyang 26
Rio de Janeiro 25
Paris 24
Frankfurt am Main 23
Palermo 23
Warsaw 23
Johannesburg 22
Brussels 21
Hebei 21
Nanchang 21
San Diego 20
Tashkent 20
Dearborn 19
Nuremberg 19
Denver 18
Stockholm 18
Atlanta 17
Baghdad 17
Poplar 17
Belo Horizonte 16
Dong Ket 16
Florence 16
Tianjin 16
Chennai 15
Guangzhou 15
Mexico City 15
Bologna 14
Noicattaro 14
Toronto 14
Vienna 14
Montreal 13
Phoenix 13
Quito 13
Washington 13
Brasília 12
Dhaka 12
Dublin 12
Jiaxing 12
Manchester 12
Turku 12
Amsterdam 11
Ankara 11
Brno 11
Porto Alegre 11
Redwood City 11
Changsha 10
Haiphong 10
The Dalles 10
Amman 9
Goiânia 9
Auburn Hills 8
Campinas 8
Totale 8.549
Salva come PNG Salva come JPEG
Nome #
L'immunoparesi nel mieloma multiplo 690
Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association 204
Autoimmune uveitis: clinical, pathogenetic, and therapeutic features 194
CD20-Mimotope Peptides: A Model to Define the Molecular Basis of Epitope Spreading 186
Clinical correlates of human leucocyte antigen (HLA)-G in systemic sclerosis 180
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 180
Anti-centromere protein A antibodies in systemic sclerosis: Significance and origin 176
CD20-depleting therapy in autoimmune diseases: from basic research to the clinic 168
Evaluation of the influence of social, demographic, environmental, work-related factors and/or lifestyle habits on Raynaud's phenomenon: a case-control study 168
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases 162
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 161
Autoantibodies to intracellular antigens: generation and pathogenetic role 159
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 155
AB0695 Subspecificities of Anti-Centromeric-Associated Protein a (CENP-A) Antibodies (AB) Can Identified a Subset of Patients at Higher Risk of Developing Pulmonary Hypertension 152
Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease 151
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 150
Clinical correlates of a subset of anti-CENP-A antibodies cross-reacting with FOXE3p53-62 in systemic sclerosis 147
Effectiveness and safety of belimumab in patients with active systemic lupus erythematosus: results from a large, nationwide, multicentric study. 146
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders. 145
Antiphospholipids syndrome complicated by a systemic capillary leak-like syndrome treated with steroids and intravenous immunoglobulins a case report 142
Anti Th/To autoantibodies: a predictor markers for interstitial lung disease in undifferentiated connective tissue disease at risk of systemic sclerosis 142
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 140
Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype 139
Severe pulmonary hypertension as the initial manifestation of systemic lupus erythematosus: a case report and review of the literature 136
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart? 136
Vasculitides: Proposal for an integrated nomenclature 134
Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department 134
CD20: A target antigen for immunotherapy of autoimmune diseases 131
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 131
Rheumatic disorders as paraneoplastic syndromes 128
Anti-carbamylated protein antibodies in patients with systemic sclerosis: an intriguing association with skin involvement 127
Human CD4 internal antigen anti-idiotypic monoclonal antibody. Immunochemical and sequence analysis 126
Extra-articular manifestations of rheumatoid arthritis: an update 124
Analisi molecolare di un anticorpo monoclonale (ACMO) anti-idiotipo 'immagine interna' dell'antigene CD4 123
Case series on amyloidosis and organ involvement: a single center experience 122
Antibiotics or No Antibiotics, That Is the Question: An Update on Efficient and Effective Use of Antibiotics in Dental Practice 122
Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease 120
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 117
Adult-onset Still's disease with elderly onset: results from a multicentre study 114
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 114
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? 111
Sars-cov-2 inflammatory syndrome. Clinical features and rationale for immunological treatment 111
Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma 108
Anticorpi monoclonali nell'immunoterapia delle malattie autoimmuni 107
Beta2-microglobulin-free HLA class I heavy chain epitope mimicry by monoclonal antibody HC-10-specific peptide 105
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study 105
Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count 101
Lupus vasculitis: An overview 101
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 100
Clinical response and analysis of regulatory T cells (Tregs) in a cohort of patients with active Systemic Lupus Erythematosus (SLE) on treatment with belimumab. 99
Beta2-m-free heavy chain levels of HLA-class I antigen combined with serum IgM or platelet count provide two reliable staging systems in multiple myeloma 98
Size variants of beta-2-microglobulin-free human leucocyte antigen class I heavy chain make different contributions to its serum increase in multiple myeloma 98
B2 microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin’s and non Hodgkin’s lymphomas 98
Echocardiographic alteration in patients with systemic lupus erythematosus affected by hepatic steatosis: a cross-sectional single center study 96
An atypical presentation of intestinal neuroendocrine tumor. 96
Epstein–Barr Virus in Salivary Samples from Systemic Lupus Erythematosus Patients with Oral Lesions 94
Immune escape of multiple myeloma cells results from low miR29b and the ensuing epigenetic silencing of proteasome genes 93
Analisi molecolare di un anticorpo monoclonale (AcMo) anti-idiotipo “immagine interna” dell’antigene CD4 93
Amicrobial pustulosis or erosive pustular dermatosis of the inguinal folds: broad of the same spectrum? 92
Endothelial cells in tumor microenvironment: insights and perspectives 90
HLA allele prevalence in disease-modifying antirheumatic drugs-responsive enthesitis and/or arthritis not fulfilling ASAS criteria: Comparison with psoriatic and undifferentiated spondyloarthritis 90
Identificazione del peptide che mima l'epitopo localizzato sulla catena pesante HLA-I non associata alla beta 2-microglobulina, riconosciuto dall'anticorpo monoclonale HC-10 90
Raynaud’s phenomenon: from molecular pathogenesis to therapy 89
Vasculiti primarie sistemiche 87
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 86
An 82-year-old woman with new onset of multiple purple-reddish nodules during treatment with abatacept for rheumatoid arthritis 85
Membrane-type metalloprotease activity and HLA class I mRNA splicing in generating tFHC variants in multiple myeloma: clinical significance 84
Efficacy, Safety, and Predictor of Response to Belimumab in a Large Nationwide Cohort Study of Patients with Active Systemic Lupus Erythematosus. 84
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 83
Ruolo degli autoanticorpi nelle patologie autoimmuni 82
Involvement of FAB subclass-specific determinants in the interaction of human IgG with Streptococcal Protein (PG) 81
The role of recombinant human erythropoietin alpha in the treatment of chronic anemia in multiple myeloma 80
Clinical use of erythropoietin 80
B2 microglobulin (b2m)-free HLA class I heavy chain as prognostic marker of multiple myeloma 80
Mieloma multiplo e gammapatie monoclonali: quadri clinici, acquisizioni eziopatogenetiche e progressi terapeutici 79
Constrictive pericarditis due to AL amyloidosis: a case report. 79
Beta-2 microglobulin-free HLA-A class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally toserum FHC expression 77
null 77
Monoclonal antibodies (mAb) in the immunotherapy (IT) of autoimmune disease (AD) 76
Minimum structural requirement for CD4 mimicry by anti-idiotipic mAb 16D7 75
Ruolo degli autoanticorpi nelle patologie autoimmuni 70
Impact of Antigen Presentation Mechanisms on Immune Response in Autoimmune Hepatitis 70
La neutropenia nei pazienti in trattamento: differenziazione dei fattori di crescita 69
Vasculiti primarie sistemiche 69
Systemic lupus erythematosus therapy: new possibilities since 50 years 69
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 68
Dosaggio della catena pesante degli antigeni di Istocompatibilita' in pazienti con mieloma multiplo (MM) 68
Functional characterization of peptides mimicking the CD20 epitope recognized by Rituximab 68
Beta 2-microglobulin-free heavy chain (FHC) of HLA class I antigen in patients with Hodgkin's and non-Hodgkin's lymphomas 67
BETA-2 microglobulin (beta2m)-free HLA Class I heavy chain as prognostic marker of multiple myeloma 67
Galectin-3 and Neutrophil-to-Lymphocyte ratio are indicative of heart remodelling and disease severity in patients with Obstructive Sleep Apnoea 67
Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity 67
Difficult therapeutic choices in a patient suffering from severe scleroderma and colon adenocarcinoma. 66
Paradoxical embolism: relationship between foramen ovale pervious and renal infarction. 65
Immunoparesisi in multiple myeloma 64
Two structurally different peptides mimic a CD20 epitope recognized by rituximab 64
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus 64
Adipose failure through adipocyte overload and autoimmunity 63
Drug resistance in multiple myeloma: Soldiers and weapons in the bone marrow niche 62
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 62
Totale 11.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.628
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.628
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021289 0 0 0 0 0 0 0 0 0 134 96 59
2021/2022808 35 83 6 34 28 65 60 45 38 43 143 228
2022/20231.530 193 201 114 140 164 216 33 180 217 11 42 19
2023/2024701 49 107 37 65 51 179 12 48 23 29 25 76
2024/20252.429 90 26 192 71 62 195 265 241 83 151 359 694
2025/20264.785 781 253 347 634 622 304 625 202 572 445 0 0
Totale 13.899